These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 26828873)
1. The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation. Wang X; Wang R; Liu G; Dong J; Zhao G; Tian J; Sun J; Jia X; Wei L; Wang Y; Li W Cell Physiol Biochem; 2016; 38(2):514-30. PubMed ID: 26828873 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of β3-adrenergic receptors contributes to atrial structural remodeling in rapid pacing induced atrial fibrillation canines. Sheng L; Shen Q; Huang K; Liu G; Zhao J; Xu W; Liu Y; Li W; Li Y Cell Physiol Biochem; 2012; 30(2):372-81. PubMed ID: 22739404 [TBL] [Abstract][Full Text] [Related]
3. β3-Adrenoceptor Impairs Mitochondrial Biogenesis and Energy Metabolism During Rapid Atrial Pacing-Induced Atrial Fibrillation. Dong J; Zhao J; Zhang M; Liu G; Wang X; Liu Y; Yang N; Liu Y; Zhao G; Sun J; Tian J; Cheng C; Wei L; Li Y; Li W J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):114-26. PubMed ID: 26130614 [TBL] [Abstract][Full Text] [Related]
4. β3-adrenoceptor mediates metabolic protein remodeling in a rabbit model of tachypacing-induced atrial fibrillation. Liu Y; Geng J; Liu Y; Li Y; Shen J; Xiao X; Sheng L; Yang B; Cheng C; Li W Cell Physiol Biochem; 2013; 32(6):1631-42. PubMed ID: 24335437 [TBL] [Abstract][Full Text] [Related]
5. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD). Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411 [TBL] [Abstract][Full Text] [Related]
6. Antiremodeling Effect of Xanthine Oxidase Inhibition in a Canine Model of Atrial Fibrillation. Yoshizawa T; Niwano S; Niwano H; Tamaki H; Nakamura H; Igarashi T; Oikawa J; Satoh A; Kishihara J; Murakami M; Fukaya H; Ako J Int Heart J; 2018 Sep; 59(5):1077-1085. PubMed ID: 30158379 [TBL] [Abstract][Full Text] [Related]
8. Aliskiren protecting atrial structural remodeling from rapid atrial pacing in a canine model. Zhao Z; Chen Y; Li W; Wang X; Li J; Yang W; Cheng L; Liu T; Liu E; Li G Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):863-71. PubMed ID: 27118660 [TBL] [Abstract][Full Text] [Related]
9. Probucol prevents atrial remodeling by inhibiting oxidative stress and TNF-α/NF-κB/TGF-β signal transduction pathway in alloxan-induced diabetic rabbits. Fu H; Li G; Liu C; Li J; Wang X; Cheng L; Liu T J Cardiovasc Electrophysiol; 2015 Feb; 26(2):211-22. PubMed ID: 25199622 [TBL] [Abstract][Full Text] [Related]
10. Activation of β(3)-adrenoceptor promotes rapid pacing-induced atrial electrical remodeling in rabbits. Yu J; Li W; Li Y; Zhao J; Wang L; Dong D; Pan Z; Yang B Cell Physiol Biochem; 2011; 28(1):87-96. PubMed ID: 21865851 [TBL] [Abstract][Full Text] [Related]
11. β3-Adrenoreceptor stimulation protects against myocardial infarction injury via eNOS and nNOS activation. Niu X; Zhao L; Li X; Xue Y; Wang B; Lv Z; Chen J; Sun D; Zheng Q PLoS One; 2014; 9(6):e98713. PubMed ID: 24911015 [TBL] [Abstract][Full Text] [Related]
12. Exchange protein activated by cyclic-adenosine monophosphate (Epac) regulates atrial fibroblast function and controls cardiac remodelling. Surinkaew S; Aflaki M; Takawale A; Chen Y; Qi XY; Gillis MA; Shi YF; Tardif JC; Chattipakorn N; Nattel S Cardiovasc Res; 2019 Jan; 115(1):94-106. PubMed ID: 30016400 [TBL] [Abstract][Full Text] [Related]
13. Linagliptin prevents atrial electrical and structural remodeling in a canine model of atrial fibrillation. Igarashi T; Niwano S; Niwano H; Yoshizawa T; Nakamura H; Fukaya H; Fujiishi T; Ishizue N; Satoh A; Kishihara J; Murakami M; Ako J Heart Vessels; 2018 Oct; 33(10):1258-1265. PubMed ID: 29721673 [TBL] [Abstract][Full Text] [Related]
14. Qiliqiangxin attenuates atrial structural remodeling in prolonged pacing-induced atrial fibrillation in rabbits. Tingting H; Guangzhong L; Yanxiang Z; DongDong Y; Li S; Li W Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):585-592. PubMed ID: 30627756 [TBL] [Abstract][Full Text] [Related]
15. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction. Sakabe M; Fujiki A; Sakamoto T; Nakatani Y; Mizumaki K; Inoue H J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1130-5. PubMed ID: 22587612 [TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits. Liu T; Zhao H; Li J; Korantzopoulos P; Li G Cardiovasc Ther; 2014 Aug; 32(4):178-83. PubMed ID: 24814361 [TBL] [Abstract][Full Text] [Related]
17. Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor. Moens AL; Leyton-Mange JS; Niu X; Yang R; Cingolani O; Arkenbout EK; Champion HC; Bedja D; Gabrielson KL; Chen J; Xia Y; Hale AB; Channon KM; Halushka MK; Barker N; Wuyts FL; Kaminski PM; Wolin MS; Kass DA; Barouch LA J Mol Cell Cardiol; 2009 Nov; 47(5):576-85. PubMed ID: 19766235 [TBL] [Abstract][Full Text] [Related]
18. Inefficacy of a highly selective T-type calcium channel blocker in preventing atrial fibrillation related remodeling. Kato T; Iwasaki YK; Duker G; Fjellstrom O; Giordanetto F; Sundqvist M; Wallin A; Wang QD; Nattel S J Cardiovasc Electrophysiol; 2014 May; 25(5):531-536. PubMed ID: 24330029 [TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase. Niu X; Watts VL; Cingolani OH; Sivakumaran V; Leyton-Mange JS; Ellis CL; Miller KL; Vandegaer K; Bedja D; Gabrielson KL; Paolocci N; Kass DA; Barouch LA J Am Coll Cardiol; 2012 May; 59(22):1979-87. PubMed ID: 22624839 [TBL] [Abstract][Full Text] [Related]
20. β3-adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling. Dal Monte M; Fornaciari I; Nicchia GP; Svelto M; Casini G; Bagnoli P Naunyn Schmiedebergs Arch Pharmacol; 2014 Jun; 387(6):533-43. PubMed ID: 24599317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]